<DOC>
	<DOCNO>NCT02170532</DOCNO>
	<brief_summary>Dr. MacIntyre colleague study inhaled medication asthma . There two new medication approve United States Food Drug Administration ( FDA ) : levalbuterol formoterol . Both drug similar standard asthma bronchodilator drug offer theoretical advantage term few side effect . There also new device deliver medication lung : breath actuate nebulizer ( BANs ) non-static chamber ( Aerochamber-max ) use meter dose inhaler ( MDIs `` puffer '' ) . The purpose study deliver new medication use several different device measure lung function , heart rate , sensation breathlessness .</brief_summary>
	<brief_title>Aerosolized Beta-Agonist Isomers Asthma</brief_title>
	<detailed_description>Patients study five separate morning . The duration study frequency visit solely dependant subject availability . Each subject receive 5 treatment order .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>stable mild moderate persistent asthma define National Asthma Education Prevention Program great 18 year age require bronchodilator therapy either routinely need ( PRN ) basis stable respect respiratory disease least four week remove recent acute exacerbation disease patient may may inhale corticosteroid unstable cardiovascular symptom unstable angina must least four week remove acute coronary syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>asthma</keyword>
</DOC>